What is the recommended starting dose of bupropion (Wellbutrin) for treating depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bupropion Dosing for Depression Treatment

The recommended starting dose of bupropion for depression is 150 mg once daily for 3 days, then increasing to 150 mg twice daily (300 mg total daily dose) for the sustained-release (SR) formulation. 1

Initial Dosing and Titration

  • For Bupropion SR (sustained-release), start with 150 mg once daily for 3 days, then increase to 150 mg twice daily (300 mg total daily dose) 2, 1
  • The second dose should not be taken late in the day to minimize the risk of insomnia 1, 3
  • For immediate-release formulations, the starting dose is typically lower at 100 mg twice daily 4
  • For extended-release (XL) formulations, start with 150 mg once daily in the morning, which can be increased to 300 mg once daily after several days 1

Dose Adjustments for Special Populations

  • For older adults (>65 years), start with a lower dose of 37.5 mg every morning, then increase by 37.5 mg every 3 days as tolerated, to a maximum of 150 mg twice daily 2, 1
  • For patients with moderate to severe hepatic impairment, the total daily dose should not exceed 150 mg daily 1, 3
  • For patients with moderate to severe renal impairment, reduce the total daily dose by half 1, 3

Maximum Dosing

  • The maximum recommended dose for bupropion SR is 400 mg per day 1
  • The maximum recommended dose for bupropion XL is 450 mg per day 1
  • Doses exceeding these limits increase the risk of seizures significantly 5

Efficacy Assessment and Monitoring

  • Clinical response should be assessed after 4-8 weeks of treatment at an adequate dose 6
  • If no response is seen after 6-8 weeks at an adequate dose, consider alternative treatment 1
  • Monitor for neuropsychiatric adverse effects, especially in individuals younger than 24 years 1, 4
  • Monitor vital signs, particularly blood pressure, as bupropion should be avoided in patients with uncontrolled hypertension 3

Clinical Considerations

  • Bupropion SR at both 150 mg/day and 300 mg/day has been shown to be more effective than placebo in treating depression 7
  • Once-daily dosing appears to be at least as effective as twice-daily dosing for some patients, offering greater convenience and potentially improved adherence 7
  • Bupropion may be particularly beneficial for patients with depression who also want to quit smoking 1, 2
  • Bupropion has shown particular benefit in bipolar and atypical depression compared to "typical" depression 8

Safety Considerations

  • Avoid in patients with seizure disorders, as bupropion lowers the seizure threshold 2, 5
  • The risk of seizures is dose-dependent and significantly increases at doses above the recommended maximum 5
  • Avoid use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOIs 2, 1
  • Common side effects include dry mouth, insomnia, headache, nausea, and agitation 6
  • Unlike many other antidepressants, bupropion has minimal sexual side effects and is less likely to cause weight gain 6

Formulation Differences

  • SR (sustained-release): Typically dosed twice daily (morning and afternoon) 1
  • XL (extended-release): Typically dosed once daily in the morning 1
  • The bioavailability between immediate-, sustained-, and extended-release formulations is similar under steady-state conditions 4

Following these dosing guidelines will help optimize treatment outcomes while minimizing the risk of adverse effects in patients with depression.

References

Guideline

Bupropion Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naltrexone-Bupropion ER for Chronic Pain and Weight Loss in Depression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Other Antidepressants.

Handbook of experimental pharmacology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.